It’s not yet known how blockchain will affect the health market. But is healthcare’s blockchain hype justified or just to be set aside?

Co-Founder and CTO, PokitDok

Tomorrow’s hospital is unlike what we have come to know. It’s transparent, efficient, and virtual, with AI the bridge between healthcare’s present and future.

Partner, Health & Life Sciences, Oliver Wyman

The future of medicine is bright, as opportunities from companies like Apple may soon overhaul the industry. But is true patient empowerment a realistic expectation?

President, CareJourney
President, Commonwealth Fund

The healthcare industry struggles with keeping insurance costs low and quality high. One solution? Walgreens’ new incentive-based care model.

What missed opportunities will incumbents one day wish they had taken advantage of? Adopting a new mentality will disrupt the industry from the inside out.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures

CVS, Aetna, and UnitedHealthcare are just a few leading names that may forever change healthcare delivery. Should traditional health systems cling to the status quo or go with the flow?

Partner, Health & Life Sciences, Oliver Wyman

Five success factors for accelerating innovation through strategic partnerships.

Partner, Health & Life Sciences, Oliver Wyman

What some of healthcare’s most influential voices had to say about the past, present, and future of the industry on the Summit's final day.

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Insights in your inbox

Subscribe
Load More